ArticleJournal of clinical medicine research2016

Efficacy and Safety of Alogliptin in Patients With Type 2 Diabetes: Analysis of the ATTAK-J Study.

Hiroshi Takeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.